Skip to main content
. 2009 Jan;32(1):141–146. doi: 10.2337/dc08-1360

Table 1.

Baseline prevalence of metabolic syndrome defined by WHO and ATP-III criteria and components in older adults without known CHD

Yes No
Metabolic syndrome defined by WHO criteria
    n 44 248
    Prevalence of WHO components (%)
        Impaired glucose metabolism (type 2 diabetes, impaired fasting glucose [110–125 mg/dl] or impaired glucose tolerance [140–199 mg/dl]) 100.0 5.2
        Obesity (BMI >30 kg/m2 and/or waist-to-hip ratio >0.9 for men and >0.85 for women) 97.7 55.2
        High triglycerides (≥150 mg/dl) 56.8 25.8
        Low HDL cholesterol (<35 mg/dl for men and <39 mg/dl for women) 11.4 1.2
        Hypertension (≥140/90 mmHg or use of antihypertensive drugs) 84.1 37.1
        Albuminuria (urinary albumin excretion rate ≥20 μg/min or albumin-to-creatinine ratio ≥30 mg/g) 9.1 2.8
Metabolic syndrome defined by ATP-III criteria
    n 40 298
    Prevalence of ATP-III components (%)
        Fasting plasma glucose >110 mg/dl 47.5 14.8
        Abdominal obesity (waist circumference >102 cm for men and >88 cm for women) 72.5 14.1
        High triglycerides (≥150 mg/dl) 80.0 22.5
        Low HDL cholesterol (<40 mg/dl for men and <50 mg/dl for women) 80.0 7.4
        Hypertension (≥130/85 mmHg or use of antihypertensive drugs) 90.0 51.7